1-(Hydroxymethyl)cyclopropane carboxylic acid, 95.0%, 250mg

2-THIOPHENECARBOXAMIDE, N-[(1S)-2-AMINO-1-[(3-FLUOROPHENYL)METHYL]ETHYL]-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-, HCL (1:1), 95%, 250mg

Boc-D-Arg-OH.HCl.H2O, >98.0%(N), 25g

6-amino-3-(2-fluorobenzyl)pyrimidine-2,4(1H,3H)-dione, 95.0%, 500mg

3',4'-dichloro-3-(3,5-dimethylphenyl)propiophenone, 97.0%, 1g

Di-tert-butyl 4-bromopyrazolidine-1,2-dicarboxylate, 97%, 500mg

3,3'-Bipyridyl>98.0%(GC)(T)1g

tert-Butyl 4-bromo-2-oxo-1,2-dihydrospiro[indole-3,4'-piperidine]-1'-carboxylate, 1g

1-methyl-1H-indol-4-amine hydrochloride hydrate, 95.0%, 1g

1,1-Dimethyl-2-morpholin-4-yl-ethylamine, 95.0%, 100mg

N-(3-(((2-((4-Hydroxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)methyl)phenyl)-N-methylmethanesulfonamide, 98%, 25mg

5-Bromo-6-fluoroindoline, 97.0%, 100mg

Objetivo IOS PL S40x/0,65 con plan corregido al infinito. Distancia de trabajo 0,36 mm